Alpha is More Than Just Ac-225: Pb-212

This month's episode of the JNM Podcast takes the discussion of Pb-212 worldwide! Researchers from the UK, Australia, and North America discuss the logistics of using lead-212 as a radionuclide imaging agent. From availability to production to transportation, Pb-212 presents both great opportunities and great challenges. Moderator Ken Herrmann, MD, leads this intercontinental panel in a discussion about other radionuclides and their pros and cons. He's joined by David Bauer, PhD, from Memorial Sloan Kettering Cancer Center, Jane Sosabowski, BSc, MSc, PhD, from Queen Mary, University of London, and Nick Fletcher, PhD, from the University of Queensland, Australia.

[@samanthahsu4123]

Thank you very much for the sharing

[@SNMChannel1]

Thanks for tuning in!

[@solipsisticful]

We are currently able to produce actinium 225 from radium 226 at research reactors here in the US. Of course this is at the research phase , but we can yield quite a bit.